Andrew Metry
Population Health, School of Medicine and Population Health
Research Fellow in Decision Modelling
a.metry@sheffield.ac.uk
+44 114 222 6253
+44 114 222 6253
Regent Court (ScHARR)
Full contact details
Andrew Metry
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
ºù«Ӱҵ
S1 4DA
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
ºù«Ӱҵ
S1 4DA
- Profile
-
I joined ScHARR (HEDS) as a Research Associate (Health Economics and Decision Modelling) in January 2019 after completing an MSc in the same field (HEDM) at ºù«Ӱҵ (ScHARR) in 2018.
Prior to this I was employed as a Pharmacoeconomist in the Egyptian Ministry of Health; I have worked on a variety of technology appraisals back there, and practiced Decision Modelling aiding decision makers towards appropriate national reimbursement schemes for different health technologies.
- Research interests
-
- Cost-Effectiveness modelling and technology appraisals
Current projects
- I mainly work on single technology appraisals associated with the ScHARR-TAG
- Publications
-
Show: Featured publications All publications
Featured publications
This person does not have any publications available.
All publications
Journal articles
- . International Wound Journal, 21(10).
- . Value in Health Regional Issues, 38, 109-117.
- . Health Technology Assessment, 27(14).
- . Value in Health, 25(12), S144-S145.
- . PharmacoEconomics, 39(8), 879-887.
- . PharmacoEconomics.
- . Health Technology Assessment, 25(21), 1-68.
- . PharmacoEconomics.
- . Health Technology Assessment, 25(39), 1-74.
- Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technology Assessment.
- A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales. Value in Health.
Conference proceedings papers
- . Value in Health, Vol. 22 (pp S577-S578)
- COST-MINIMIZATION ANALYSES OF BIOLOGICAL THERAPIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS FROM THE EGYPTIAN HEALTHCARE SYSTEM PERSPECTIVE. VALUE IN HEALTH, Vol. 20(9) (pp A535-A536)
- . Value in Health, Vol. 18(7) (pp A646-A646)
- . Value in Health, Vol. 18(7) (pp A437-A437)
- DEVELOPING HOSPITAL BASED HTA FOR EGYPTIAN CANCER PATIENTS. VALUE IN HEALTH, Vol. 18(3) (pp A102-A102)
Preprints
- Professional activities and memberships
-
- Member of International Society for Pharmacoeconomics and Outcomes Research (ISPOR): Abstract reviewer for annual conferences and congresses